Avadel Pharmaceuticals (AVDL) Gross Profit (2016 - 2020)
Historic Gross Profit for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q2 2020 value amounting to $6.8 million.
- Avadel Pharmaceuticals' Gross Profit fell 5114.84% to $6.8 million in Q2 2020 from the same period last year, while for Mar 2021 it was $6.8 million, marking a year-over-year decrease of 8442.74%. This contributed to the annual value of $16.6 million for FY2020, which is 6476.53% down from last year.
- Avadel Pharmaceuticals' Gross Profit amounted to $6.8 million in Q2 2020, which was down 5114.84% from $9.8 million recorded in Q1 2020.
- Avadel Pharmaceuticals' Gross Profit's 5-year high stood at $48.6 million during Q1 2017, with a 5-year trough of $6.8 million in Q2 2020.
- In the last 5 years, Avadel Pharmaceuticals' Gross Profit had a median value of $26.2 million in 2018 and averaged $24.7 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Gross Profit surged by 104198.25% in 2016, and later crashed by 5344.57% in 2018.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Gross Profit stood at $40.5 million in 2016, then decreased by 24.18% to $30.7 million in 2017, then crashed by 45.84% to $16.6 million in 2018, then tumbled by 48.39% to $8.6 million in 2019, then decreased by 20.69% to $6.8 million in 2020.
- Its Gross Profit was $6.8 million in Q2 2020, compared to $9.8 million in Q1 2020 and $8.6 million in Q4 2019.